Similar Papers

Paper Title
Journal
Date
Author
614P - Microsatellite instability status in metastatic colorectal cancer and effect of immune checkpoint inhibitors on survival in MSI-high metastatic colorectal cancer
...
Annals of Oncology | VOL. 30
, et. al. ...
01 Oct 2019
894TiP - PROSTRATEGY: A Spanish Genitourinary Oncology Group (SOGUG) multi-arm multistage (MAMS) phase III trial of immunotherapy strategies in high-volume metastatic hormone-sensitive prostate cancer
...
Annals of Oncology | VOL. 30
, et. al. ...
01 Oct 2019
881P - Implications of single nucleotide polymorphisms (SNPs) in androgen related-genes in outcome of metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone (Abi) and enzalutamide (Enza)
I.M Aragon ... E Castro
Annals of Oncology | VOL. 30
I.M Aragon, et. al.I.M Aragon ... E Castro
01 Oct 2019
975P - mTOR mutations are not associated with shorter PFS and OS in patients treated with mTOR inhibitors
C Suarez Rodriguez ... J Carles
Annals of Oncology | VOL. 30
C Suarez Rodriguez, et. al.C Suarez Rodriguez ... J Carles
01 Oct 2019
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Reply to the Letter to the Editor regarding ‘PFS, OS or toxicity: what is the most important factor in the treatment of EGFR-mutated lung cancer?’ by T. Nishimura and H. Fujimoto
E Felip ... S.-H Lee
Annals of Oncology | VOL. 36
E Felip, et. al.E Felip ... S.-H Lee
01 Feb 2025
Expanding the role of CDK4/6 inhibitors in early breast cancer: insights from the NATALEE trial
Marcela Carausu ... Michail Ignatiadis
Annals of Oncology | VOL. 36
Marcela Carausu, et. al.Marcela Carausu ... Michail Ignatiadis
01 Feb 2025
FOxTROT: is anti-EGFR a good dancing partner?
Clara Montagut ... Joana Vidal
Annals of Oncology | VOL. -
Clara Montagut, et. al.Clara Montagut ... Joana Vidal
01 Feb 2025
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.